Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

CENTRAL AFRICAN REPUBLIC-BANGUI-CHINESE MEDICAL TEAM

(230217) -- BANGUI, Feb. 17, 2023 (Xinhua) -- Wang Xiaoqin, a member of the 19th Chinese medical team dispatched to the Central African Republic, informs a patient of the medicine dosage at the Hospital of Friendship in Bangui, Central African Republic, Feb. 14, 2023. The 19th Chinese medical team dispatched to the Central African Republic arrived in the country in June 2022. Since then, team members have been on China's international medical aid mission here, providing services for local people. (Xinhua/Li Yahui)

E

A-bomb survivor publishes book, warns of radiation damage

HIROSHIMA, Japan - Mitsuo Kodama, who survived the 1945 U.S. atomic bombing of Hiroshima from within a 1-kilometer radius from the hypocenter and was exposed to an extremely high dosage of approximately 4,600 millisieverts of radiation, poses in front of the Atomic Dome in Hiroshima with his book "Hibakusha, Hiroshima karano Message" (Hibakusha, Message from Hiroshima) on March 25, 2014.

E

TÜRKIYE-ISTANBUL-JOURNALIST-INTERVIEW

(221125) -- ISTANBUL, Nov. 25, 2022 (Xinhua) -- Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, speaks in an interview with Xinhua in Istanbul, Türkiye, Nov. 22, 2022. A Turkish journalist who had lived in Qatar for six years strongly denounced Western media's attacks on Qatar during the country's preparations for the 2022 FIFA World Cup. "The handling and the coverage of this World Cup by the Western press, has come to a point of smearing. Unfortunately, the dosage of criticism has increased," Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, told Xinhua in a recent interview in Istanbul. TO GO WITH "Interview: Turkish journalist slams Western media's unfair attacks on Qatar" (Xinhua/Shadati)

E

TÜRKIYE-ISTANBUL-JOURNALIST-INTERVIEW

(221125) -- ISTANBUL, Nov. 25, 2022 (Xinhua) -- Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, checks information about Qatar, in Istanbul, Türkiye, Nov. 22, 2022. A Turkish journalist who had lived in Qatar for six years strongly denounced Western media's attacks on Qatar during the country's preparations for the 2022 FIFA World Cup. "The handling and the coverage of this World Cup by the Western press, has come to a point of smearing. Unfortunately, the dosage of criticism has increased," Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, told Xinhua in a recent interview in Istanbul. TO GO WITH "Interview: Turkish journalist slams Western media's unfair attacks on Qatar" (Xinhua/Shadati)

E

TÜRKIYE-ISTANBUL-JOURNALIST-INTERVIEW

(221125) -- ISTANBUL, Nov. 25, 2022 (Xinhua) -- Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, speaks in an interview with Xinhua in Istanbul, Türkiye, Nov. 22, 2022. A Turkish journalist who had lived in Qatar for six years strongly denounced Western media's attacks on Qatar during the country's preparations for the 2022 FIFA World Cup. "The handling and the coverage of this World Cup by the Western press, has come to a point of smearing. Unfortunately, the dosage of criticism has increased," Feyza Gumusluoglu, foreign news department coordinator of Istanbul-based broadcaster EkoTurk, told Xinhua in a recent interview in Istanbul. TO GO WITH "Interview: Turkish journalist slams Western media's unfair attacks on Qatar" (Xinhua/Shadati)

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

Secondary level students at a local school in Nepali capital Kathmandu display their vaccination card after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu presses the point of injection after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

Secondary level students of a local school in Nepali capital Kathmandu hold the point of injecture while they take rest after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

Olivier Veran and Elisabeth Borne visit a vaccination center - Sainte-Geneviève-des-Bois

Illustrations of the preparation of dosage of vaccins at a vaccination center during the visit of the vaccination center in Sainte-Geneviève-des-Bois near Paris, France, on April 24, 2021. Photo by Raphael Lafargue/ABACAPRESS.COM

E

Osaka_RedCross_Hospital-Press_Conference

Osaka Red Cross - Press Conference : March 10, 2000 (March 11, 2000) Police on Saturday raided the Osaka Red Cross Hospital over the death last year of a cancer patient who was accidentally given an incorrect dosage of an anticancer agent. The hospital in Osaka's Tennoji Ward is accused of professional negligence resulting in death. Following the instructions of a 27-year-old male intern who was the patient's attending physician, a nurse administered 80 milligrams of an anticancer agent intravenously to the patient on the morning on Dec. 27 last year, investigators said. By the evening of the same day, the 63-year-old patient was suffering stomach pains, diarrhea and other side affects. He died of multiple organ failure on Jan. 13, the investigators said. The doctor had intended the patient to receive 10 mg of an anticancer agent but accidentally prescribed a different agent and gave incorrect guidance to the nurse on the adequate dosage, the investigators said.

E

Worker exposed to radiation in nuclear accident dies

TOKYO, Japan - File photo shows Hisashi Ouchi, 35, who died late at night Dec. 21 after being exposed to a massive dosage of radiation in Japan's worst nuclear accident in September. His death came at a Tokyo hospital 83 days after the Sept. 30 accident at a nuclear fuel plant run by JCO Co. in Tokaimura, Ibaraki Prefecture.